Monday, Jun 5, 2023
English News
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
    • Rewind
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
  • Rewind
Home | Health | Johnson And Johnson Delays Covid Vaccine Roll Out In Europe

Johnson and Johnson delays Covid vaccine roll out in Europe

The US Food and Drug Administration (FDA) and the Centres for Disease Control and Prevention (CDC) on Tuesday called for a pause on the Johnson & Johnson vaccine after six recipients of the jab developed a rare

By IANS
Published Date - 04:25 PM, Wed - 14 April 21
Johnson and Johnson delays Covid vaccine roll out in Europe
Isis Gardner, left, receives a dose of the Pfizer COVID-19 vaccine at the Banning Recreation Center. Photo: AP
whatsapp facebook twitter telegram

New York: Johnson and Johnson (J&J) has decided to delay the roll out of its Covid-19 vaccine in Europe after federal health agencies in the US recommended a pause in the use of the jab in the country.

The US Food and Drug Administration (FDA) and the Centres for Disease Control and Prevention (CDC) on Tuesday called for a pause on the Johnson & Johnson vaccine after six recipients of the jab developed a rare and severe type of blood clot.

“We have made the decision to proactively delay the roll out of our vaccine in Europe and pause vaccinations in all Janssen Covid-19 vaccine clinical trials while we update guidance for investigators and participants,” Johnson & Johnson said in a statement on Tuesday.

“We have been working closely with medical experts and health authorities, and we strongly support the open communication of this information to healthcare professionals and the public.”

The European Union (EU) last month authorised the use of Johnson & Johnson’s Covid-19 vaccine after the European Medicines Agency (EMA) made a positive recommendation based on scientific assessment of its efficacy and safety.

But reports of some people developing rare blood clots after receiving the vaccine have put strains in the vaccination drive.

In the US, the FDA and the CDC have urged the states across the country to pause the use of the single-dose vaccine while they investigate cases of blood clots.

“The safety and well-being of the people who use our products is our number one priority. We are aware of an extremely rare disorder involving people with blood clots in combination with low platelets in a small number of individuals who have received our Covid-19 vaccine,” Johnson & Johnson said.

  • Follow Us :
  • Tags
  • Covid-19
  • Europe
  • J&J
  • Johnson and Johnson

Related News

  • Rahul Gandhi’s images from Bharat Jodo Yatra shown at Times Square billboard

    Rahul Gandhi’s images from Bharat Jodo Yatra shown at Times Square billboard

  • Covid-19 impacted relationships among married Couples: study reveals

    Covid-19 impacted relationships among married Couples: study reveals

  • India logs 288 new COVID-19 cases, two deaths

    India logs 288 new COVID-19 cases, two deaths

  • Cats can play role in transmission of Covid-19: Study

    Cats can play role in transmission of Covid-19: Study

  • This company in Telangana is example of IT Rural hub

    This company in Telangana is example of IT Rural hub

  • From honey hunt to thriving business: Journey of a young entrepreneur from Warangal

    From honey hunt to thriving business: Journey of a young entrepreneur from Warangal

Latest News

  • Make customers’ rights charter enforceable, says RBI panel

    4 mins ago
  • Telangana government to provide paid maternity leave for all ASHA workers

    6 mins ago
  • Patancheru MLA congratulates Shanvitha for winning World ITF U-18 tennis tournament

    9 mins ago
  • Women’s hockey Junior Asia Cup: India register hard-fought 2-1 victory over Malaysia

    14 mins ago
  • Hyderabad: Power substation to end woes of Ramakrishnapur citizens

    19 mins ago
  • Kothagudem: Scribe kills wife, portrays death as heart attack

    24 mins ago
  • Gangula wants people to know how Telangana overcame power crisis

    24 mins ago
  • Educational institutions from Hyderabad shine in NIRF rankings

    27 mins ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam